Search results
- 1.0436793 - ÚMG 2015 RIV US eng J - Journal Article
Vlková, Veronika - Štěpánek, Ivan - Hrušková, Veronika - Šenigl, Filip - Mayerová, Veronika - Šrámek, Martin - Šímová, Jana - Bieblová, Jana - Indrová, Marie - Hejhal, Tomáš - Dérian, N. - Klatzmann, D. - Six, A. - Reiniš, Milan
Epigenetic regulations in the IFNγ signalling pathway: IFNγ-mediated MHC class I upregulation on tumour cells is associated with DNA demethylation of antigen-presenting machinery genes.
OncoTarget. Roč. 5, č. 16 (2014), s. 6923-35. ISSN 1949-2553
R&D Projects: GA ČR GAP301/10/2174; GA MZd NT14461
EU Projects: European Commission(XE) 18933 - CLINIGENE
Grant - others:French state funds within the Investissements d’Avenir program(FR) ANR-11-IDEX-0004-02
Institutional support: RVO:68378050
Keywords : IFNγ signalling pathway * DNA demethylation * tumour
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 6.359, year: 2014
Permanent Link: http://hdl.handle.net/11104/0241959File Download Size Commentary Version Access 0436793.pdf 13 1.2 MB Publisher’s postprint require - 2.0381574 - ÚMG 2013 RIV US eng J - Journal Article
Mikyšková, Romana - Indrová, Marie - Polláková, Veronika - Bieblová, Jana - Šímová, Jana - Reiniš, Milan
Cyclophosphamide-induced myeloid-derived suppressor cell population is immunosuppressive but not identical to myeloid-derived suppressor cells induced by growing TC-1 tumors.
Journal of Immunotherapy. Roč. 35, č. 5 (2012), s. 374-384. ISSN 1524-9557. E-ISSN 1537-4513
R&D Projects: GA ČR(CZ) GPP301/11/P220; GA ČR GA301/09/1024; GA ČR GA301/07/1410
EU Projects: European Commission(XE) 18933 - CLINIGENE
Institutional research plan: CEZ:AV0Z50520514
Institutional support: RVO:68378050
Keywords : myeloid-derived suppressor cells * cyclophosphamide * all-trans-retinoic acid * IL-12 * HPV16
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 3.463, year: 2012
Permanent Link: http://hdl.handle.net/11104/0216407File Download Size Commentary Version Access 0381574.pdf 7 7.1 MB Publisher’s postprint require - 3.0371265 - ÚMG 2012 RIV GB eng J - Journal Article
Šímová, Jana - Polláková, Veronika - Indrová, Marie - Mikyšková, Romana - Bieblová, Jana - Štěpánek, Ivan - Bubeník, Jan - Reiniš, Milan
Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status.
British Journal of Cancer. Roč. 105, č. 10 (2011), s. 1533-1541. ISSN 0007-0920. E-ISSN 1532-1827
R&D Projects: GA ČR GA301/07/1410; GA ČR GAP301/10/2174; GA ČR GA301/09/1024
EU Projects: European Commission(XE) 18933 - CLINIGENE
Institutional research plan: CEZ:AV0Z50520514
Keywords : 5-azacytidine * MHC class I downregulation * tumour chemoimmunotherapy
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 5.042, year: 2011
Permanent Link: http://hdl.handle.net/11104/0204817File Download Size Commentary Version Access 0371265.pdf 5 5.6 MB Publisher’s postprint require - 4.0352661 - ÚMG 2011 RIV GB eng J - Journal Article
Reiniš, Milan
Immunotherapy of MHC class I-deficient tumors.
Future Oncology. Roč. 6, č. 10 (2010), s. 1577-1589. ISSN 1479-6694. E-ISSN 1744-8301
R&D Projects: GA ČR GA301/07/1410; GA ČR GAP301/10/2174; GA AV ČR IAA500520807; GA AV ČR IAA500520605
EU Projects: European Commission(XE) 18933 - CLINIGENE
Institutional research plan: CEZ:AV0Z50520514
Keywords : tumor vaccine * MHC class I expression * antigen presenting machinery
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 2.455, year: 2010
Permanent Link: http://hdl.handle.net/11104/0192124 - 5.0346751 - ÚMG 2011 RIV GR eng J - Journal Article
Bubeník, Jan - Šímová, Jana
Genetically modified cellular vaccines against human papillomavirus type 16 (HPV16)-associated tumors: adjuvant treatment of minimal residual disease after surgery/chemotherapy.
Journal of Balkan Union of Oncology. Roč. 14, č. 1 (2009), s. 169-173. ISSN 1107-0625. E-ISSN 2241-6293
R&D Projects: GA ČR GA301/06/0774; GA ČR GA301/07/1410
EU Projects: European Commission(XE) 18933 - CLINIGENE
Institutional research plan: CEZ:AV0Z50520514
Keywords : residual tumour disease * HPV16 * cellular vaccines
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 0.600, year: 2009
Permanent Link: http://hdl.handle.net/11104/0187687 - 6.0346747 - ÚMG 2011 RIV GR eng J - Journal Article
Reiniš, Milan - Štěpánek, Ivan - Šímová, Jana - Bieblová, Jana - Přibylová, Hana - Indrová, Marie - Bubeník, Jan
Induction of protective immunity against MHC class I-deficient, HPV16-associated tumours with peptide and dendritic cell-based vaccines.
International Journal of Oncology. Roč. 36, č. 3 (2010), s. 545-551. ISSN 1019-6439. E-ISSN 1791-2423
R&D Projects: GA AV ČR IAA500520605; GA AV ČR IAA500520807
EU Projects: European Commission(XE) 18933 - CLINIGENE
Institutional research plan: CEZ:AV0Z50520514
Keywords : MHC class I-deficient tumours * CpG oligodeoxynucleotides * human papilloma virus
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 2.571, year: 2010
Permanent Link: http://hdl.handle.net/11104/0187685File Download Size Commentary Version Access 0346747.pdf 3 515.8 KB Publisher’s postprint require - 7.0333598 - ÚMG 2011 RIV DE eng J - Journal Article
Šímová, Jana - Indrová, Marie - Bieblová, Jana - Mikyšková, Romana - Bubeník, Jan - Reiniš, Milan
Therapy for minimal residual tumour disease: beta-galactosylceramide inhibits growth of recurrent HPV16-associated neoplasms after surgery and chemotherapy.
International Journal of Cancer. Roč. 126, č. 12 (2010), s. 2997-3004. ISSN 0020-7136. E-ISSN 1097-0215
R&D Projects: GA ČR GA301/06/0774; GA AV ČR IAA500520807; GA ČR GA301/07/1410; GA ČR GA301/09/1024
EU Projects: European Commission(XE) 18933 - CLINIGENE
Institutional research plan: CEZ:AV0Z50520514
Keywords : beta-galactosylceramide * tumour immunotherapy * NKT cells
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 4.926, year: 2010
Permanent Link: http://hdl.handle.net/11104/0178543File Download Size Commentary Version Access 0333598.pdf 5 380.1 KB Publisher’s postprint require - 8.0318305 - ÚMG 2009 RIV GR eng J - Journal Article
Indrová, Marie - Bieblová, Jana - Rossowska, J. - Kuropka, P. - Pajtasz-Piasecka, E. - Bubeník, Jan - Reiniš, Milan
HPV 16-associated tumours: IL-12 can repair the absence of cytotoxic and proliferative responses of tumour infiltrating cells after chemotherapy.
[HPV 16-asociované nádory: IL-12 může obnovit cytotoxické a proliferační odpovědi buněk infiltrujících nádor po chemoterapii.]
International Journal of Oncology. Roč. 34, č. 1 (2009), s. 173-180. ISSN 1019-6439. E-ISSN 1791-2423
R&D Projects: GA ČR GA301/06/0774
EU Projects: European Commission(XE) 18933 - CLINIGENE
Grant - others:Polish Ministry of Science and Higher Education(PL) N401 235334
Institutional research plan: CEZ:AV0Z50520514
Keywords : HPV 16 * vaccines * tumour-infiltrating cells
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 2.447, year: 2009
Permanent Link: http://hdl.handle.net/11104/0167760 - 9.0306792 - ÚMG 2009 RIV GB eng J - Journal Article
Manning, Jasper - Indrová, Marie - Lubyová, B. - Přibylová, Hana - Bieblová, Jana - Hejnar, Jiří - Šímová, Jana - Jandlová, Táňa - Bubeník, Jan - Reiniš, Milan
Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen-processing machinery components in a murine model for human papilloma virus 16-associated tumours.
[Indukce povrchové exprese MHC molekul I. třídy a epigenetická aktivace složek antigen prezentující dráhy na myším modelu nádorů asociovaných s lidským papillomavirem HPV16.]
Immunology. Roč. 123, č. 2 (2008), s. 218-227. ISSN 0019-2805. E-ISSN 1365-2567
R&D Projects: GA ČR GA301/04/0492; GA ČR GA301/07/1410
EU Projects: European Commission(XE) 18933 - CLINIGENE
Grant - others:Liga proti rakovině, Praha(CZ) -
Institutional research plan: CEZ:AV0Z50520514
Keywords : major hiostocompatibility system class I * epigenetics * HPV 16
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 3.432, year: 2008
Permanent Link: http://hdl.handle.net/11104/0159721 - 10.0306790 - ÚMG 2009 RIV GR eng J - Journal Article
Indrová, Marie - Bieblová, Jana - Bubeník, Jan - Reiniš, Milan
IL-12 immunotherapy of minimal residual disease in murine models of HPV16-associated tumours: induction of immune responses, cytokine production and kinetics of immune cell subsets.
[Imunoterapie minimální zbytkové choroby interleukinem 12 na myším modelu nádorů asociovaných s virem HPV 16: Indukce imunitní odpovědi, produkce cytokinů a kinetika subpopulací imunních buněk.]
International Journal of Oncology. Roč. 32, č. 2 (2008), s. 499-507. ISSN 1019-6439. E-ISSN 1791-2423
R&D Projects: GA ČR GA301/06/0774
EU Projects: European Commission(XE) 18933 - CLINIGENE
Institutional research plan: CEZ:AV0Z50520514
Keywords : HPV 16 * MHC class I-positive and -deficient tumours * immature myeloid cells
Subject RIV: EB - Genetics ; Molecular Biology
Impact factor: 2.234, year: 2008
Permanent Link: http://hdl.handle.net/11104/0159719